Bone Mineral Density Changes Among Clinical Subtypes of Parkinson's Disease
NCT ID: NCT03806517
Last Updated: 2019-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
75 participants
OBSERVATIONAL
2019-02-10
2019-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Motor Imagery Training
NCT07193355
Exploring Sarcopenia in Parkinson's Disease Patients by Combining Serum Biomarker Levels
NCT06511531
Determination of Muscle Strength in Parkinsonian Patients Through the Use of an Isokinetic Dynamometer
NCT02101528
The Relationship Between Upper Extremity Function and Balance and Functional Mobility in Parkinson's Disease
NCT06591975
Balance Confidence and Kinesiophobia in Parkinson's Disease
NCT06751797
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All patients admitted to the outpatient clinic will be evaluated in terms of inclusion criteria. The control group consisted of people who do not have any orthopedic, neurological or metabolic disorders which may affect the BMD.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tremor dominant type group
Tremor dominant type (TDT) group will consist of the patients with tremor premotor symptoms.
No interventions assigned to this group
PIGD dominant type group
Postural instability and gait difficulty dominant type (PIGDT) group will consist of the patients with axial premotor symptoms.
No interventions assigned to this group
Healthy control group
Healthy control group will consist of the subjects with same age and sex matched individuals in PD group.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
For Control group
The similar age and sex-matched healthy individuals who have no orthopedic, metabolic and neurological disorders, and steroid use will be included in the study.
40 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ordu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sevim ACARÖZ CANDAN
Head of Department of Physiotherapy and Rehabilitation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sevim ACARÖZ CANDAN
Role: PRINCIPAL_INVESTIGATOR
Ordu University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sevim ACARÖZ CANDAN
Ordu, Altinordu, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ordu University 1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.